Seven Eight Capital, LP Edwards Lifesciences Corp Transaction History

Seven Eight Capital, LP

$918 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $31,990 - $42,141	441 Added 2.57%	17,613 $1.68 Million
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $9.87 Million - $12.4 Million	-159,956 Reduced 90.31%	17,172 $1.31 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $11.8 Million - $15.9 Million	169,746 Added 2299.46%	177,128 $12.3 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $1.7 Million - $1.97 Million	-20,930 Reduced 73.93%	7,382 $696,000
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $714,752 - $813,408	9,625 Added 51.51%	28,312 $2.34 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $5.34 Million - $6.83 Million	-78,117 Reduced 80.7%	18,687 $1.39 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $7.97 Million - $10.4 Million	96,804 New	96,804 $7.88 Million
Q2 2022 Aug 04, 2022	SELL	$86.5 - $128.27 $279,222 - $414,055	-3,228 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $329,126 - $414,281	3,228 New	3,228 $380,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $2.89 Million - $3.54 Million	-27,124 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $1.37 Million - $1.63 Million	13,300 Added 96.21%	27,124 $3.07 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $1.16 Million - $1.45 Million	13,824 New	13,824 $1.43 Million
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $444,478 - $565,626	-6,200 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $483,768 - $629,568	-7,200 Reduced 53.73%	6,200 $495,000
Q2 2020 Aug 06, 2020	SELL	$57.54 - $76.95 $161,112 - $215,460	-2,800 Reduced 17.28%	13,400 $939,000
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $2.12 Million - $3.28 Million	-40,529 Reduced 71.44%	16,200 $3.06 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $2.65 Million - $3.03 Million	36,900 Added 186.09%	56,729 $13.2 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $1.22 Million - $1.5 Million	19,829 New	19,829 $4.36 Million
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $2.68 Million - $3.09 Million	-48,029 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $2.3 Million - $3.08 Million	48,029 New	48,029 $9.19 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $1.76 Million - $2.25 Million	-47,329 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$33.79 - $39.39 $114,615 - $133,610	3,392 Added 7.72%	47,329 $5.33 Million
Q3 2017 Oct 16, 2017	BUY	$36.29 - $38.83 $1.59 Million - $1.71 Million	43,937	43,937 $4.8 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account